Corbus Pharmaceuticals Holdings, Inc. has unveiled significant insights regarding its investigational drug, CRB-701, during a recent panel discussion focused on head and neck cancer. The event...
Monopar Therapeutics, a biopharmaceutical company based in the United States, has announced the pricing of a significant underwritten registered offering. On October 3, 2023, the company...
